Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review
Abstract Fibrin biopolymers, previously referred as “fibrin glue” or “fibrin sealants”, are natural biomaterials with diverse applications on health. They have hemostatic, adhesive, sealant, scaffold and drug delivery properties and have become widely used in medical and dental procedures. Historically, these biomaterials are produced from human fibrinogen and human or animal thrombin, and the possibility of transmission of infectious diseases by human blood is not ruled out. In the 1990s, to overcome this problem, a new heterologous biomaterial composed of a thrombin-like enzyme purified from Crotalus durissus terrificus venom and a cryoprecipitate rich in fibrinogen extracted from buffaloes Bubalus bubalis blood has been proposed. Therefore, a systematic review of studies on exclusively heterologous fibrin sealants published between 1989 and 2018 was carried out using the following databases: PubMed, SciELO and Google Scholar. The keyword used was “heterologous fibrin sealant”. The search resulted in 35 scientific papers in PubMed, four in SciELO and 674 in Google Scholar. After applying the inclusion/exclusion criteria and complete reading of the articles, 30 studies were selected, which formed the basis of this systematic review. It has been observed that the only completely heterologous sealant is the one produced by CEVAP/UNESP. This heterologous biopolymer is proven effective by several studies published in refereed scientific journals. In addition, clinical trials phase I/II for the treatment of chronic venous ulcers authorized by the Brazilian Health Regulatory Agency (ANVISA) were completed. Preliminary results have indicated a safe and promising effective product. Phase III clinical trials will be proposed and required to validate these preliminary findings.
Main Authors: | , , , , , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Centro de Estudos de Venenos e Animais Peçonhentos (CEVAP/UNESP)
2019
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1678-91992019000100207 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S1678-91992019000100207 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S1678-919920190001002072019-11-07Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic reviewBuchaim,Daniela VieiraCassaro,Claudia VilalvaShindo,João Vitor Tadashi CosinColetta,Bruna Botteon DellaPomini,Karina TorresRosso,Marcelie Priscila de OliveiraCampos,Leila Maria GuissoniFerreira Jr,Rui SeabraBarraviera,BeneditoBuchaim,Rogério Leone Fibrin sealant Snake venom Thrombin-like enzyme Cryoprecipitate coagulum Abstract Fibrin biopolymers, previously referred as “fibrin glue” or “fibrin sealants”, are natural biomaterials with diverse applications on health. They have hemostatic, adhesive, sealant, scaffold and drug delivery properties and have become widely used in medical and dental procedures. Historically, these biomaterials are produced from human fibrinogen and human or animal thrombin, and the possibility of transmission of infectious diseases by human blood is not ruled out. In the 1990s, to overcome this problem, a new heterologous biomaterial composed of a thrombin-like enzyme purified from Crotalus durissus terrificus venom and a cryoprecipitate rich in fibrinogen extracted from buffaloes Bubalus bubalis blood has been proposed. Therefore, a systematic review of studies on exclusively heterologous fibrin sealants published between 1989 and 2018 was carried out using the following databases: PubMed, SciELO and Google Scholar. The keyword used was “heterologous fibrin sealant”. The search resulted in 35 scientific papers in PubMed, four in SciELO and 674 in Google Scholar. After applying the inclusion/exclusion criteria and complete reading of the articles, 30 studies were selected, which formed the basis of this systematic review. It has been observed that the only completely heterologous sealant is the one produced by CEVAP/UNESP. This heterologous biopolymer is proven effective by several studies published in refereed scientific journals. In addition, clinical trials phase I/II for the treatment of chronic venous ulcers authorized by the Brazilian Health Regulatory Agency (ANVISA) were completed. Preliminary results have indicated a safe and promising effective product. Phase III clinical trials will be proposed and required to validate these preliminary findings.info:eu-repo/semantics/openAccessCentro de Estudos de Venenos e Animais Peçonhentos (CEVAP/UNESP)Journal of Venomous Animals and Toxins including Tropical Diseases v.25 20192019-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1678-91992019000100207en10.1590/1678-9199-jvatitd-2019-0038 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Buchaim,Daniela Vieira Cassaro,Claudia Vilalva Shindo,João Vitor Tadashi Cosin Coletta,Bruna Botteon Della Pomini,Karina Torres Rosso,Marcelie Priscila de Oliveira Campos,Leila Maria Guissoni Ferreira Jr,Rui Seabra Barraviera,Benedito Buchaim,Rogério Leone |
spellingShingle |
Buchaim,Daniela Vieira Cassaro,Claudia Vilalva Shindo,João Vitor Tadashi Cosin Coletta,Bruna Botteon Della Pomini,Karina Torres Rosso,Marcelie Priscila de Oliveira Campos,Leila Maria Guissoni Ferreira Jr,Rui Seabra Barraviera,Benedito Buchaim,Rogério Leone Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review |
author_facet |
Buchaim,Daniela Vieira Cassaro,Claudia Vilalva Shindo,João Vitor Tadashi Cosin Coletta,Bruna Botteon Della Pomini,Karina Torres Rosso,Marcelie Priscila de Oliveira Campos,Leila Maria Guissoni Ferreira Jr,Rui Seabra Barraviera,Benedito Buchaim,Rogério Leone |
author_sort |
Buchaim,Daniela Vieira |
title |
Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review |
title_short |
Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review |
title_full |
Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review |
title_fullStr |
Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review |
title_full_unstemmed |
Unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review |
title_sort |
unique heterologous fibrin biopolymer with hemostatic, adhesive, sealant, scaffold and drug delivery properties: a systematic review |
description |
Abstract Fibrin biopolymers, previously referred as “fibrin glue” or “fibrin sealants”, are natural biomaterials with diverse applications on health. They have hemostatic, adhesive, sealant, scaffold and drug delivery properties and have become widely used in medical and dental procedures. Historically, these biomaterials are produced from human fibrinogen and human or animal thrombin, and the possibility of transmission of infectious diseases by human blood is not ruled out. In the 1990s, to overcome this problem, a new heterologous biomaterial composed of a thrombin-like enzyme purified from Crotalus durissus terrificus venom and a cryoprecipitate rich in fibrinogen extracted from buffaloes Bubalus bubalis blood has been proposed. Therefore, a systematic review of studies on exclusively heterologous fibrin sealants published between 1989 and 2018 was carried out using the following databases: PubMed, SciELO and Google Scholar. The keyword used was “heterologous fibrin sealant”. The search resulted in 35 scientific papers in PubMed, four in SciELO and 674 in Google Scholar. After applying the inclusion/exclusion criteria and complete reading of the articles, 30 studies were selected, which formed the basis of this systematic review. It has been observed that the only completely heterologous sealant is the one produced by CEVAP/UNESP. This heterologous biopolymer is proven effective by several studies published in refereed scientific journals. In addition, clinical trials phase I/II for the treatment of chronic venous ulcers authorized by the Brazilian Health Regulatory Agency (ANVISA) were completed. Preliminary results have indicated a safe and promising effective product. Phase III clinical trials will be proposed and required to validate these preliminary findings. |
publisher |
Centro de Estudos de Venenos e Animais Peçonhentos (CEVAP/UNESP) |
publishDate |
2019 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1678-91992019000100207 |
work_keys_str_mv |
AT buchaimdanielavieira uniqueheterologousfibrinbiopolymerwithhemostaticadhesivesealantscaffoldanddrugdeliverypropertiesasystematicreview AT cassaroclaudiavilalva uniqueheterologousfibrinbiopolymerwithhemostaticadhesivesealantscaffoldanddrugdeliverypropertiesasystematicreview AT shindojoaovitortadashicosin uniqueheterologousfibrinbiopolymerwithhemostaticadhesivesealantscaffoldanddrugdeliverypropertiesasystematicreview AT colettabrunabotteondella uniqueheterologousfibrinbiopolymerwithhemostaticadhesivesealantscaffoldanddrugdeliverypropertiesasystematicreview AT pominikarinatorres uniqueheterologousfibrinbiopolymerwithhemostaticadhesivesealantscaffoldanddrugdeliverypropertiesasystematicreview AT rossomarcelieprisciladeoliveira uniqueheterologousfibrinbiopolymerwithhemostaticadhesivesealantscaffoldanddrugdeliverypropertiesasystematicreview AT camposleilamariaguissoni uniqueheterologousfibrinbiopolymerwithhemostaticadhesivesealantscaffoldanddrugdeliverypropertiesasystematicreview AT ferreirajrruiseabra uniqueheterologousfibrinbiopolymerwithhemostaticadhesivesealantscaffoldanddrugdeliverypropertiesasystematicreview AT barravierabenedito uniqueheterologousfibrinbiopolymerwithhemostaticadhesivesealantscaffoldanddrugdeliverypropertiesasystematicreview AT buchaimrogerioleone uniqueheterologousfibrinbiopolymerwithhemostaticadhesivesealantscaffoldanddrugdeliverypropertiesasystematicreview |
_version_ |
1756429237132197888 |